Holen Sie sich die Stockscreener-App
22.77
0.18%
0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt FMS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.75
Offen:
$22.9
24-Stunden-Volumen:
174.76K
Relative Volume:
0.30
Marktkapitalisierung:
$12.72B
Einnahmen:
$22.18B
Nettoeinkommen (Verlust:
$1.36B
KGV:
11.85
EPS:
1.9216
Netto-Cashflow:
$2.00B
1W Leistung:
-0.70%
1M Leistung:
-6.75%
6M Leistung:
-8.73%
1J Leistung:
-1.64%
1-Tages-Spanne:
$22.73
$22.97
1-Wochen-Bereich:
$22.62
$23.51
52-Wochen-Spanne:
$20.95
$30.46
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Firmenname
Fresenius Medical Care Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare FMS vs HCA, THC, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.77 | 12.71B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
HCA
Hca Healthcare Inc
|
537.70 | 119.10B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
226.52 | 19.54B | 21.31B | 2.37B | 2.53B | 15.49 |
|
ENSG
Ensign Group Inc
|
209.98 | 12.11B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
193.28 | 11.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Herabstufung | Goldman | Buy → Neutral |
| 2025-10-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-09-02 | Herabstufung | UBS | Neutral → Sell |
| 2024-12-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Eingeleitet | Berenberg | Buy |
| 2024-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2023-08-14 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Fortgesetzt | Citigroup | Neutral |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-03-07 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-03 | Herabstufung | Jefferies | Buy → Underperform |
| 2022-10-26 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-27 | Hochstufung | Jefferies | Underperform → Buy |
| 2022-02-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-11-23 | Eingeleitet | HSBC Securities | Hold |
| 2021-11-11 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-06-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Hochstufung | UBS | Neutral → Buy |
| 2018-08-28 | Hochstufung | HSBC Securities | Hold → Buy |
| 2018-07-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Hochstufung | UBS | Sell → Neutral |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-07-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2016-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2015-08-13 | Herabstufung | Societe Generale | Buy → Hold |
| 2015-07-31 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Bestätigt | Feltl & Co. | Hold |
| 2013-01-14 | Hochstufung | HSBC Securities | Neutral → Overweight |
Alle ansehen
Fresenius Medical Care Ag Adr Aktie (FMS) Neueste Nachrichten
Fresenius Medical Care publishes its Annual Report 2025: The power of care - Fresenius Medical Care
Advancing kidney care: Introducing high-volume hemodiafiltration to the U.S. - Fresenius Medical Care
Fresenius Medical Care Faces a Transition Year in 2026 on New Product Launch Activities - Morningstar
Fresenius Medical Care marks World Kidney Day and National Kidney Month - Fresenius Medical Care
Fresenius Medical Care: An Undervalued Stock to Buy Now and Hold for the Long Term - Morningstar
5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand - Finviz
Research in brief: Nocturnal home hemodialysis - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $1.11, revenue topped estimates - Investing.com Australia
Fresenius Medical Care published Report on Form 20-F for fiscal year 2025 - Fresenius Medical Care
Fresenius Medical Care Q4 2025 slides: margin surge, flat 2026 outlook - Investing.com
Earnings call transcript: Fresenius Medical Care Q4 2025 beats EPS expectations - Investing.com
Fresenius Medical Care falls nearly 7% despite earnings beat - Investing.com South Africa
Fresenius Medical Care falls 7% after 2026 flat growth outlook and cost update - Investing.com
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band - Fresenius Medical Care
Uncovering Potential: Fresenius Medical Care's Earnings Preview - Sahm
Research in Brief: Hemodiafiltration and hospitalization burden in ESKD - Fresenius Medical Care
FedEx Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Allstate Upgraded, Amazon Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Statement from Fresenius Medical Care on Upcoming Winter Storm - Fresenius Medical Care
Research in brief: Implementation of Online High-Volume Hemodiafiltration - Fresenius Medical Care
Annual Press Conference 2026 - Fresenius Medical Care
18 of the Best Stocks and ETFs to Buy Based on 2026 Expert Forecasts - Morningstar
6 New 5-Star Stocks - Morningstar
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds By Investing.com - Investing.com South Africa
Goldman Sachs downgrades Fresenius Medical Care stock on 2026 headwinds - Investing.com
Reasons to Add Fresenius Medical Stock to Your Portfolio Now - Finviz
Fresenius Medical Care accelerates second tranche of share buyback - Investing.com
Fresenius Medical Care accelerates second tranche of share buyback By Investing.com - Investing.com India
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned - Fresenius Medical Care
Finding purpose and perseverance: A dialysis nurse’s quiet heroism - Fresenius Medical Care
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - Finviz
Fresenius Medical Care names Charles Hugh-Jones as new global CMO By Investing.com - Investing.com South Africa
Fresenius Medical Care names Charles Hugh-Jones as new global CMO - Investing.com India
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board - Fresenius Medical Care
DoorDash Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Research in brief: Time on treatment - Fresenius Medical Care
Alphabet Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
U.S. Arteriovenous Fistula Devices Market Trends Analysis Report 2025-2033: Lucrative Opportunities Stem from Rising ESRD Cases, Driving Demand for AVF Solutions - GlobeNewswire Inc.
Finanzdaten der Fresenius Medical Care Ag Adr-Aktie (FMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
2.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):